Wednesday, February 10, 2010, 4:29pm SGT - The Singapore stock market closes in 31 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

MAP Pharmaceuticals, Inc. (MAPP)

At 5:00AM SGT: 14.98 USD   0.00 (0.00%)  
 MORE ON MAPP 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 MAP Pharmaceuticals, Inc. (NGM:MAPP) Delayed quote dataEdit
Last Trade:14.98 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:14.98
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:16.20
Day's Range:N/A - N/A
52wk Range:1.57 - 16.80
Volume:0
Avg Vol (3m):207,508
Market Cap:366.92M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Use Y! Toolbar to track stocks
 Add MAPP to Portfolio   Download Data

 HEADLINES 
•MAP PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Feb 5)
•Best Performing Stocks Year to Date
at Seeking Alpha (Tue, Feb 2)
•FDA Clears the Way for MAP Pharmaceuticals
at Seeking Alpha (Sat, Jan 16)
•Healthcare Stock Alert for MAP Pharmaceuticals Inc. issued by Beacon Equity
GlobeNewswire (Wed, Jan 13)
•Map Pharmaceuticals Shares on Good News for Migraine Drug
at Fox Business (Tue, Jan 12)
•[$$] MedCath Moves Up; Berry Slips 5.4%
at The Wall Street Journal Online (Tue, Jan 12)
•McMoRan Exploration, MAP Pharmaceuticals: Biggest Price Gainers (MMR, MAPP)
at The Wall Street Journal Online (Tue, Jan 12)
•Map Pharmaceuticals Inc and K Tron International Lead Small-Cap Percentage Gainers
SmallCapInvestor.com (Tue, Jan 12)
•Biotech Stocks: MAP, Inhibitex, Vivus lead drug stocks north
at MarketWatch (Tue, Jan 12)
•MAP Pharma says FDA doesn't need new Levadex study
AP (Tue, Jan 12)
•UPDATE - MAP says FDA waives second trial for migraine drug
at Reuters (Tue, Jan 12)
•Biotech Stocks: MAP and Vivus lead drug stocks north
at MarketWatch (Mon, Jan 11)
More Headlines for MAPP...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.27
EPS Est (in 2 years) (Dec-10) :-1.89
Avg Rec (current)*:1.4
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
MAP Pharmaceuticals, Inc., a development stage company, engages in developing drug candidates to treat local respiratory and treatable diseases primarily in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices